Compare · ATKR vs TMO
ATKR vs TMO
Side-by-side comparison of Atkore Inc. (ATKR) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- ATKR operates in Miscellaneous, while TMO operates in Industrials - the two are in different parts of the market.
- TMO is the larger of the two at $228.17B, about 72.1x ATKR ($3.16B).
- Over the past year, ATKR is up 63.0% and TMO is up 25.3% - ATKR leads by 37.7 points.
- ATKR has been more active in the news (19 items in the past 4 weeks vs 9 for TMO).
- TMO has more recent analyst coverage (25 ratings vs 15 for ATKR).
- Company
- Atkore Inc.
- Thermo Fisher Scientific Inc
- Price
- $93.69+0.01%
- $610.12-1.24%
- Market cap
- $3.16B
- $228.17B
- 1M return
- +0.26%
- +6.30%
- 1Y return
- +63.02%
- +25.30%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NYSE
- IPO
- 2016
- News (4w)
- 19
- 9
- Recent ratings
- 15
- 25
Atkore Inc.
Atkore Inc. manufactures and distributes electrical raceway products, and mechanical products and solutions (MP&S) in the United States and internationally. The company offers electrical raceway products, including electrical conduits and fittings, armored cables and fittings, and cable trays and mounting systems and fittings. It also provides MP&S products comprising metal framing and fittings, mechanical pipes, and barbed tapes, as well as construction services related to design, fabrication and installation, modular support structures, and fall protection. The company offers its products under the Allied Tube & Conduit, AFC Cable Systems, Heritage Plastics, Unistrut, Power-Strut, Cope, and Calpipe brands, as well as other sub-brands. It serves a group of end markets, including new construction; maintenance, repair, and remodel, as well as infrastructure; diversified industrials; alternative power generation; healthcare; data centers; and government through electrical, industrial, and mechanical contractors, as well as original equipment manufacturers. The company was formerly known as Atkore International Group Inc. and changed its name to Atkore Inc. in February 2021. Atkore Inc. was founded in 1959 and is headquartered in Harvey, Illinois.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest ATKR
- Chief Accounting Officer Alvey James William was granted 9 shares, increasing direct ownership by 0.17% to 5,449 units (SEC Form 4)
- Director Edmonds Franklin S. Jr. was granted 10 shares, increasing direct ownership by 0.35% to 2,844 units (SEC Form 4)
- Director Wynn Betty R. was granted 28 shares, increasing direct ownership by 0.14% to 20,616 units (SEC Form 4)
- President and CEO Waltz William E Jr. was granted 242 shares, increasing direct ownership by 0.20% to 123,653 units (SEC Form 4)
- Director James Wilbert W Jr was granted 60 shares, increasing direct ownership by 0.35% to 17,191 units (SEC Form 4)
- VP, Chief HR Officer Lowe Leangela W. was granted 36 shares, increasing direct ownership by 0.10% to 36,063 units (SEC Form 4)
- Pres. Safety & Infrastructure Lamps Mark F. was granted 47 shares, increasing direct ownership by 0.13% to 35,850 units (SEC Form 4)
- Director Isbell Jeri L was granted 98 shares, increasing direct ownership by 0.32% to 30,656 units (SEC Form 4)
- Director Schrock Michael V was granted 8 shares, increasing direct ownership by 0.04% to 22,187 units (SEC Form 4)
- Director Kershaw Justin A was granted 66 shares, increasing direct ownership by 0.35% to 18,750 units (SEC Form 4)
Latest TMO
- Thermo Fisher Scientific to Present at the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026
- Chairman & CEO Casper Marc N exercised 275 shares at a strike of $309.63 and sold $172,439 worth of shares (275 units at $627.05) as part of a pre-agreed trading plan (SEC Form 4)
- Sr. Vice President & CFO Meyer James covered exercise/tax liability with 31 shares, decreasing direct ownership by 0.53% to 5,830 units (SEC Form 4)
- Chairman & CEO Casper Marc N exercised 20,000 shares at a strike of $309.63 and sold $12,561,823 worth of shares (20,000 units at $628.09) as part of a pre-agreed trading plan, decreasing direct ownership by 0.00% to 123,925 units (SEC Form 4)
- Sr. VP and Chief HR Officer Britt Lisa P. sold $7,014,093 worth of shares (11,440 units at $613.12) and exercised 11,440 shares at a strike of $418.32, decreasing direct ownership by 0.00% to 14,784 units (SEC Form 4)
- Executive Vice President Shafer Michael D exercised 25,500 shares at a strike of $370.58 and sold $15,300,000 worth of shares (25,500 units at $600.00) as part of a pre-agreed trading plan (SEC Form 4)
- Thermo Fisher Scientific Completes Sale of its Microbiology Business to Astorg
- VP & Chief Accounting Officer Holmes Joseph R. exercised 420 shares at a strike of $309.63 and sold $245,620 worth of shares (420 units at $584.81) (SEC Form 4)
- Chairman & CEO Casper Marc N exercised 275 shares at a strike of $309.63 and sold $2,862,002 worth of shares (4,883 units at $586.12) as part of a pre-agreed trading plan (SEC Form 4)
- Sr. VP and Chief HR Officer Britt Lisa P. exercised 5,850 shares at a strike of $309.63 and sold $3,393,000 worth of shares (5,850 units at $580.00), decreasing direct ownership by 0.00% to 14,784 units (SEC Form 4)